G protein activation in rat ponto-mesencephalic nuclei is enhanced by combined treatment with a Mu opioid and an adenosine A1 receptor agonist

Sleep

Volumn 24, Issue 1, 2001, Pages 52-62

  Tanase, D ^a   Martin, W A ^a   Baghdoyan, H A ^a   Lydic, R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenosine; Dorsal raphe nucleus; Laterodorsal tegmental nucleus; Nociception; Opioids; Pedunculopontine tegmental nucleus; Periaqueductal gray; Pontine reticular formation; REM sleep

Indexed keywords

4 SULFOPHENYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN STEM RESPONSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; MALE; MESENCEPHALON; NONHUMAN; PONS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SLEEP;

EID: 0035253476     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/24.1.52     Document Type: Article

References (77)

1. The role of purines in nociception
2. Adenosine receptor activation and nociception
3. Classification of adenosine receptors mediating antinociception in the rat spinal cord
4. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opiold agonist-induced antinociception in mice
5. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine
6. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: Dissociation from gastrointestinal effects in mice
7. Morphine effects on human REM state, waking state, and NREM sleep
8. Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week
9. Postoperative sleep disturbances: Mechanisms and clinical implications
10. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia
11. Adenosine infusion during isoflurane-nitrous oxide anaesthesia: Indications of perioperative analgesic effect
12. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist
13. Sleep disruption and increased apneas after pontine microinjection of morphine
14. N6(L-phenyl-isopropyl) adenosine (L-PIA) increases slow-wave sleep (S2) and decreases wakefulness in rats
15. The effects of adenosine and 2′deoxycoformycin on sleep and wakefulness in rats
16. Adenosine analogs and sleep in rats
17. Role of adenosine in sleep in rats
18. Adenosine inhibition of mesopontine cholinergic neurons: Implications for EEG arousal
19. Restoration of brain energy metabolism as the function of sleep
20. 1 adenosine receptors mimics the electroencephalographic effects of sleep deprivation
21. Role of adenosine in behavioral state modulation: A microdialysis study in the freely moving cat
22. Adenosine: A mediator of the sleep-inducing effects of prolonged wakefulness
23. Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: An in vivo microdialysis study
24. Enhancement of rapid eye movement sleep in the rat by cholinergic and adenosinergic agonists infused into the pontine reticular formation
25. Acute and chronic opiate regulation of adenylate cyclase in brain: Specific effects in locus coeruleus
26. Adenosine receptor subtypes: Characterization and therapeutic regulation
27. 1 receptor agonist enhances opioid-induced G protein activation in pontomesencephalic nuclei of rat
28. The rat brain in stereotaxic coordinates. Fourth ed.
29. 35S]guanylyl 5′-(γ-thio)triphosphate binding in REM sleep-related brain stem nuclei of rat
30. Opioids activate G proteins in REM sleep-related brain stem nuclei of rat
31. 35S]thio]-triphosphate binding
32. 35S]GTPγS binding
33. 35S] guanosine 5′- (γ-thio) triphosphate autoradiography
34. Light microscopic localization of brain opiate receptors: A general autoradiographic method which preserves tissue quality
35. Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni
36. 3H]guanylylimidodiphosphate from platelet membranes. Implications for receptor-Ni stoichiometry
37. Adenosine-containing neurons in the brain localized by immunocytochemistry
38. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications
39. Peripheral and spinal mechanisms of nociception
40. Mechanisms of action of caffeine
41. Caffeine reduces low-frequency delta activity in the human EEG
42. Injections of drugs into the lateral ventricle of the cat
43. Preliminary data on the possible role of adenosine
44. The electrophysiology of adenosine in the mammalian central nervous system
45. Microdialysis of cat pons reveals enhanced acetylcholine release during state-dependent respiratory depression
46. Cholinergic reticular mechanisms influence state-dependent ventilatory response to hypercapnea
47. Pedunculopontine stimulation alters respiration and increases ACh release in the pontine reticular formation
48. Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation and respiratory rate
49. Location and quantification of muscarinic receptor subtypes in rat pons: Implications for REM sleep generation
50. M2 muscarinic receptor subtype in the feline medial pontine reticular formation modulates the amount of rapid eye movement sleep
51. Mechanisms affecting neuronal excitability in brainstem cholinergic centers and their impact on behavioral state
52. Importance of the ventrolateral region of the periaqueductal gray and adjacent tegmentum in the control of paradoxical sleep as studied by muscimol microinjections in the cat
53. Activity of periaqueductal gray neurons during warming of the preoptic/anterior hypothalamic area
54. Microinjection of opiates into the periaqueductal gray matter attenuates neuropathic pain symptoms in rats
55. Distinct cell groups in the lumbosacral cord of the cat project to different areas in the periaqueductal gray
56. Three times as many lamina I neurons project to the periaqueductal gray than to the thalamus: A retrograde tracing study in the cat
57. Intrathecal adenosine administration: A phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain
58. Modulation of spinal pain mechanisms by spinal cord stimulation and the potential role of adjuvant pharmacotherapy
59. Adenosine reduces secondary hyperalgesia in two human models of cutaneous inflammatory pain
60. Adenosine and opiate-like substances mediates antinociception in the spinal cord
61. Reduced anti-allodynic effect of the adenosine A1-receptor agonist R-phenylisopropyladenosine on repeated intrathecal administration and lack of cross-tolerance with morphine in a rat model of central pain
62. Spinal cord morphology after chronic intrathecal administration of adenosine in the rat
63. 1 receptor agonist R-phenylisopropyl adenosine reduces presumed pain behaviour in a rat model of central pain
64. Intrathecal adenosine: Interactions with spinal clonidine and neostigmine in rat models of acute nociception and postoperative hypersensitivity
65. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn
66. 35S]GTPγS binding in brain. Modulation by endogenous adenosine
67. G proteins in cellular control
68. Synergistic interaction of muscarinic and opioid receptors with Gs-linked neurotransmitter receptors to stimulate adenylyl cyclase activity in rat olfactory bulb
69. G-protein-coupled receptor dimers in the lime light
70. Dimerization of G-protein-coupled receptors: Implications for drug design and signaling
71. Opioids and their complicated receptor complexes
72. The effect of cutaneous and deep pain on the electroencephalogram during sleep - An experimental study
73. Cholinomimetics, but not morphine, increase antinociceptive behavior from pontine reticular regions regulating rapid-eye-movement sleep
74. Cholinergic mechanisms regulating REM sleep